Home

Christina Rossi

CIK 1756941 · Chief Operating Officer · last filed 2026-06-05

Christina Rossi is a Chief Operating Officer who has filed 36 SEC Form 4 insider transactions across 3 companies since 2018. The most recent filing, for CGON, was dated Jun 5, 2026. Across all open-market trades the lifetime net is −$3.4M, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

3

Total Filings

36

Lifetime Open-Market Net

-$3.37M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CGON Director — $75.86 — $0 2 2026-06-05
Blueprint Medicines Corp (BPMC) Delisted Chief Operating Officer 20,628 $129.46 $2.67M -$3.37M 28 2025-07-21
XLO Director — $8.88 — $0 4 2025-06-12

Recent Filings

36 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-05 CGON Grant (A) — $0 EDGAR
2025-11-26 CGON Grant (A) — $0 EDGAR
2025-07-21 Blueprint Medicines Corp (BPMC) Delisted Mixed −63,546 $0 EDGAR
2025-07-08 Blueprint Medicines Corp (BPMC) Delisted Sell (S) −1,172 -$150.3K EDGAR
2025-06-12 XLO Grant (A) — $0 EDGAR
2025-05-21 Blueprint Medicines Corp (BPMC) Delisted Sell (S) −2,274 -$228.6K EDGAR
2025-05-07 Blueprint Medicines Corp (BPMC) Delisted Sell (S) −2,274 -$231.4K EDGAR
2025-03-26 Blueprint Medicines Corp (BPMC) Delisted Sell (S) −2,274 -$216.1K EDGAR
2025-03-24 Blueprint Medicines Corp (BPMC) Delisted Notice (144) −9,096 -$811.4K EDGAR
2025-03-07 Blueprint Medicines Corp (BPMC) Delisted Sell (S) −6,495 -$576.8K EDGAR
Showing 1–10 of 36
Page 1 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.